The impact of interrupting enzyme replacement therapy in late-onset Pompe disease.

Nevertheless, the reported adverse events of reduced muscle endurance and reduced/worsened pulmonary function correspond to the findings in objective measurements, even if some of them did not reach statistical significance.

also in 111,027 other papers